American journal of obstetrics and gynecology
-
Am. J. Obstet. Gynecol. · Jun 2014
Multicenter StudyPreventability of severe acute maternal morbidity.
We sought to assess potential preventability of severe acute maternal morbidity (SAMM) cases admitted to intensive-care units (ICUs) or high-dependency units (HDUs). ⋯ The majority of SAMM cases were potentially preventable or required improvement in care. Themes around substandard care related to delay in diagnosis and treatment for postpartum hemorrhage and septicemia. These findings can inform clinical educational programs and policies to improve maternal outcomes. This study has now been expanded to a national New Zealand audit of all SAMM cases admitted to an ICU/HDU.
-
Am. J. Obstet. Gynecol. · May 2013
Randomized Controlled Trial Multicenter Study Comparative StudyA randomized trial comparing conventional and robotically assisted total laparoscopic hysterectomy.
The purpose of this study was to compare operative time and intra- and postoperative complications between total laparoscopic hysterectomy and robotic-assisted total laparoscopic hysterectomy. ⋯ Although laparoscopic and robotic-assisted hysterectomies are safe approaches to hysterectomy, robotic-assisted hysterectomy requires a significantly longer operative time.
-
Am. J. Obstet. Gynecol. · Feb 2013
Randomized Controlled Trial Multicenter StudyA randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina.
We sought to determine whether 4000 IU/d (vs 2000 IU/d) of vitamin D during pregnancy is safe and improves maternal/neonatal 25-hydroxyvitamin D [25(OH)D] in a dose-dependent manner. ⋯ Maternal supplementation with vitamin D 2000 and 4000 IU/d during pregnancy improved maternal/neonatal vitamin D status. Evidence of risk reduction in infection, preterm labor, and preterm birth was suggestive, requiring additional studies powered for these endpoints.
-
Am. J. Obstet. Gynecol. · Sep 2012
Multicenter Study Comparative StudySafety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study.
The 2009-2010 A/H1N1 pandemic provided a unique setting to study the safety of MF59-adjuvanted vaccination in pregnancy. ⋯ There was no evidence of a safety risk for MF59-adjuvanted A/H1N1 vaccination in pregnant women; protection was observed against premature birth.